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Abstract 
Review on t(1;17)(p36;q21) SPOP/PRDM16 
translocation in astrocytic tumor, with data on the 
genes involved. 
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Clinics and pathology 
Disease 
A t(1;17)(p36;q21) was found in a case of 
astrocytoma grade I-II, but no further data is 
available (Yoshihara et al 2015). 
Clinics 
Grade I astrocytomas are pilocytic astrocytoma and 
subependymal giant cell astrocytoma, the latter 
being the most common central nervous system 
neoplasm in  tuberous sclerosis; they are slow 
growing tumors; they typically occur during the 
first two decades of life. Grade II astrocytomas are 
pilomyxoid astrocytoma occurring most often in 
infants and very young children, diffuse 
astrocytoma, seen at any age, but often between 
ages 30-40, and  pleomorphic xanthoastrocytoma,  
typically developing in children and young adults. 
Genes involved and 
proteins 
PRDM16 (PR domain containing 16) 
Location 
1p36.32 
DNA / RNA 
11 splice variants 
Protein 
1276 amino acids and smaller proteins. Contains a 
N-term PR domain; 7 Zinc fingers, a proline-rich 
domain, and 3 Zinc fingers in the C-term. Binds 
DNA.  
Transcription activator; PRDM16 has an intrinsic 
histone methyltransferase activity. PRDM16 forms 
a transcriptional complex with CEBPB. PRDM16 
plays a downstream regulatory role in mediating 
TGFB signaling (Bjork et al., 2010).  
PRDM16 induces brown fat determination and 
differentiation. PRDM16 is expressed selectively in 
the earliest stem and progenitor hematopoietic cells, 
and is required for the maintenance of the 
hematopoietic stem cell pool during development. 
PRDM16 is also required for survival, cell-cycle 
regulation and self-renewal in neural stem cells 
(Chuikov et al., 2010; Kajimura et al., 2010; Aguilo 
et al., 2011; Chi and Cohen, 2016). 
SPOP (speckle type BTB/POZ 
protein) 
Location 
17q21.33 
DNA / RNA 
24 splice variants 
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Protein 
374 amino acids SPOP comprises a N-term MATH 
domain (Meprin And TRAF Homology; substrate 
recognition and binding), a BTB/POZ domain 
(Bric-a-brac, Tramtrack and Broad complex/ Pox 
virus and Zinc finger; connects to the CUL3 - 
RBX1 (Cullin 3-RING box 1) scaffold protein), a 
3-box domain (facilitating CUL3 binding and 
resembling to F-/SOCS-boxes) and a C-terminal 
nuclear localization sequence. SPOP is a E3 
ubiquitin ligase adaptor protein that participates in 
the degradation of various substrates. AR (androgen 
receptor), DAXX, BMI1, BRMS1 and PDX1 are 
targets of SPOP. SPOP is critically involved in 
SETD2 (a tumor suppressor) stability. SPOP 
enables homology-directed DNA repair of double 
strand breaks, and mutant SPOP promotes genomic 
rearrangements within chromosomes. SPOP 
suppresses gastric tumorigenesis through inhibiting 
hedgehog/ GLI2 signaling pathway. SPOP is 
frequently mutated in prostate and endometrial 
cancers. TMPRSS2 - ERG fusions, frequently seen 
in prostate carcinoma, encode N-terminal-truncated 
ERG proteins that are resistant to the SPOP-
mediated degradation. Decreased expression of 
SPOP is associated with poor prognosis in glioma. 
On the other hand, SPOP is highly expressed in 
clear cell renal cell carcinoma (Zhuang et al., 2009; 
Mani, 2014; Zeng et al., 2014; Karnes et al., 2015; 
Ding et al., 2015; Rider and Cramer, 2015). 
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